Work

Ctni-30. Alliance A071601: Phase Ii Trial of Braf/mek Inhibition in Recurrent Papillary Craniopharyngiomas

Year: 2025

Type: article

Study design: Clinical Trial

Source: Neuro-Oncology

DOI: 10.1093/neuonc/noaf201.0527

Authors: Priscilla Brastianos, Susan Geyer, Sarah Reed, Brian Kabat, Elizabeth Gerstner, Timothy Kaufmann, Marissa Barbaro, Yoon Jae Choi, Macarena De La Fuente, Glenn Lesser, Priya Kumthekar, Shivangi Vora, Michael Knopp, A John Iafrate, Daniel Cahill, Paul Brown, Helen Shih, Sandro Santagata, Frederick Barker, Evanthia Galanis

Institutions: Massachusetts General Hospital, Mayo Clinic, New York University, UC Irvine Health, University of Miami, Wake Forest University Health Sciences, Northwestern University, University of Cincinnati, Brigham and Women's Hospital

Language: English

Topic: Pituitary Gland Disorders and Treatments

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416140767

FWCI:

Cites:

Cited by:

Related to: